# The High Price of Insulin Is Killing US Citizens

**URL:** <https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676>\
**Category:** The BBQ Pit\
**Created:** [June 18, 2019, 1:12pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676 "2019-06-18T13:12:47Z")\
**Posts on this page:** 20\
**Page:** 6

<div class="post-metadata">

**Author:** ![Grim\_Render](https://avatars.discourse-cdn.com/v4/letter/g/a87d85/32.png) [@Grim\_Render](https://boards.straightdope.com/u/Grim_Render)\
**Post date:** [June 23, 2019, 7:29pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/101 "2019-06-23T19:29:28Z")

</div>

Its called “_lack of price elasticty_”. An economics term. Roughly put, price elasticity is the customers ability to refuse to purchase a product if the price is too high. In the case of a drug necessary for life, this ability does not exist. A consequence of this is that in a market, jacking up prices pays off more than underselling competitors until a significant number of customers have been priced out.

Its often believed to be one of the big reasons market-based healthcare end in market failure.

---

<div class="post-metadata">

**Author:** ![John.St](https://avatars.discourse-cdn.com/v4/letter/j/b38774/32.png) [@John.St](https://boards.straightdope.com/u/John.St)\
**Post date:** [June 24, 2019, 1:03am UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/102 "2019-06-24T01:03:48Z")

</div>

> [@Broomstick](#):
>
> The drug companies keep coming out with new tweaks and new formulas to justify keeping this under patent and jacking up the costs but really, basic insulin should be made and available to all who need it as a cost that can actually be met without destitution and ruin. There is no reason this can’t be done other than greed and callous indifference to suffering, disability, and death.

1. People with Diabetes 1 must be told, that because the old patents have expired, old fashioned insuline can be had for as little as $10 a month. Not so easy to use, but it keeps you alive.

2. The drug companies need a certain amount to finance development and production. The exorbitant rise in prices are caused by discounts demanded by the drug wholesalers in the US. I happen to know, that Danish Novo pays more than US$ 15 billion in discounts per year, and the wholesalers who control the sales to US hospitals and health insurance companies have become more and more greedy every year. Check Congress and diabetes.

---

<div class="post-metadata">

**Author:** ![puzzlegal](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/puzzlegal/32/3827_2.png) [@puzzlegal](https://boards.straightdope.com/u/puzzlegal)\
**Post date:** [June 24, 2019, 2:38am UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/103 "2019-06-24T02:38:35Z")

</div>

> [@Treppenwitz](#):
>
> My **bolding** added.
> 
> TLDR: being off-patent isn’t enough, there is also a period you have to wait before you can apply to market a copy product; and the FDA need to reclassify insulins from chemical drugs to biologicals before copy drugs can be authorised. They are doing this now.
> 
> Detail:
> 
> Upthread I linked to [this FDA statement](https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-agencys-continued-efforts-bring-competition-insulin) on attempts to bring competition into the insulin market. I’ll give the technical explanation of what I understand the situation to be. If this is unclear, tell me how and I’ll try to clarify. And of course I’m cutting corners with these explanations.
> 
> Back in the day, drugs were pretty much always chemicals. By which I mean they were simple molecular structures - [link](https://en.wikipedia.org/wiki/Simvastatin) to show the chemical structure of simvastatin, as an example.
> 
> This was patent protected, of course (and typically molecules were also protected with further patents on synthetic processes used and so on). Once the patents all expire, you can make and sell the molecule - in principle. But (in principle) if you want a licence to market the drug, you should do all the preclinical testing and clinical trials that would be expected for a new drug - after all, you should know that it is safe and effective - right?
> 
> This is of course absurd and unacceptable for all manner of reasons - not least because doing needless clinical trials on humans for a chemical whose properties are well understood is pointless and unethical. Over the years rules for the licensing of generics were developed, based on the fact that the properties of the chemical were well understood. After a certain time has elapsed since the originator product - Zocor in the example of simvastatin - was first marketed (the period of “data exclusivity”), you are allowed to say to the FDA “Guys, this is our application for our simvastatin product - for all the preclinical tests and clinical studies, can you just refer to the stuff that was provided with the application for Zocor?”. So the Zocor data was used for the generic simvastatin applications - and it’s possible to do this because, y’know, a chemical is just a chemical, it doesn’t matter who makes it or even (with caveats) how it’s made. All you really have to show is that your generic is absorbed at the same speed and to the same extent as the originator in a bioequivalence test. No preclinical testing, no clinical trials.
> 
> HOWEVER - these days there are a lot of _biological_ drugs (like EPO, for example). And because the folding of these complex molecules is critical to how they work, who makes them and how they are made is critically important to their properties. So you can’t just make a generic and support it with a bioequivalence test. Even after you have shown that it has the same “structure” in terms of chemical bonds, a (limited) clinical and pre-clinical package is required to show that it works in the same way as the originator. These are _biosimilar_ producs - it’s more difficult and expensive than developing a chemical generic, but it’s the best way to get to cheap copy products for biologicals onto the market.
> 
> And here’s the complicating factor with insulins - they are\* really old\* biological drugs. So old that they were classified as chemical drugs because there wasn’t a classification for biological drugs at the time. And once you start classifying examples in a particular way, then it’s hard to change what you do with further examples as they arrive.
> 
> So insulins ended up in a class where a copy of the drug would have to be a generic; but with no mechanism for making a generic, because it isn’t a chemical drug. Hence the profound significance of the FDA announcement that they will solve this - by reclassifying all insulins as biologicals, thus making the development of biosimilar products possible:
> 
> So, to answer your question - being off-patent isn’t enough, there is also a period you have to wait before you can apply to market a copy product; and the FDA need to reclassify insulins from chemical drugs to biologicals before copy drugs can be authorised. They are doing this now.
> 
> OK, so that was long and complicated, but I hope it makes sense and helps. I’m sure there are bits that need further explanation - so treat this as a Mini-AMA: just ask and I’ll do my best to explain.
> 
> j
> 
> Disclaimer - there are many drugs - eg inhalers, ointments - which are outside the scope of this explanation.

Thank you.

I’m sure there are other issues for other drugs. For instance, as best as i can tell, the problem with the EpiPen boiled down to not many drug companies, and none that really wanted to make a cheaper version. I tried to talk a friend into just buying some epinephrine and a syringe (which, you know, people used to use.) but he was too squeamish and insurance was paying.

---

<div class="post-metadata">

**Author:** ![Wesley\_Clark](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/wesley_clark/32/20581_2.png) [@Wesley\_Clark](https://boards.straightdope.com/u/Wesley_Clark)\
**Post date:** [June 24, 2019, 2:44am UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/104 "2019-06-24T02:44:09Z")

</div>

> [@John.St](#):
>
> 1. People with Diabetes 1 must be told, that because the old patents have expired, old fashioned insuline can be had for as little as $10 a month. Not so easy to use, but it keeps you alive.
> 
> 2. The drug companies need a certain amount to finance development and production. The exorbitant rise in prices are caused by discounts demanded by the drug wholesalers in the US. I happen to know, that Danish Novo pays more than US$ 15 billion in discounts per year, and the wholesalers who control the sales to US hospitals and health insurance companies have become more and more greedy every year. Check Congress and diabetes.

As far as point 2, insulin prices have been creeping up over the last 10-20 years. If anything production costs should go down due to advances in productivity and patents should be expiring. Both should drive prices down instead of up.

> **[New Report Shows Price of Insulin Doubled From 2012 to 2016 | BioSpace](https://www.biospace.com/article/new-report-shows-price-of-insulin-doubled-from-2012-to-2016/)**
>
> In October, the Minnesota Attorney General filed a lawsuit against three of the biggest insulin manufacturers over price gouging claims. One month later the American Diabetes Association published recommendations and public policy solutions.

> [@](#):
>
> The Minnesota AG lawsuit lays out some of the increased pricing of insulin. As an example, the cost of Novo Nordisk’s Levemir increased from $120.64 for 100 units/ml vial in 2012 to $293.75 in 2018, the lawsuit said. Likewise, the cost of Eli Lilly’s Humalog jumped from $122.60 for 100 units/ml vial in 2011 to $274.70 in 2017 and Sanofi-Aventis’ Lantus increased from 99.35 in 2010 when it first entered the market to $269.54

An easy cure for this issue is to make it legal and easy for Americans to buy insulin from overseas and have it shipped here. But obviously that is illegal.

---

<div class="post-metadata">

**Author:** ![Treppenwitz](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/treppenwitz/32/3445_2.png) [@Treppenwitz](https://boards.straightdope.com/u/Treppenwitz)\
**Post date:** [June 24, 2019, 9:21am UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/105 "2019-06-24T09:21:23Z")

</div>

> [@puzzlegal](#):
>
> Thank you.
> 
> **I’m sure there are other issues for other drugs.** For instance, as best as i can tell, the problem with the EpiPen boiled down to not many drug companies, and none that really wanted to make a cheaper version. I tried to talk a friend into just buying some epinephrine and a syringe (which, you know, people used to use.) but he was too squeamish and insurance was paying.

(My bolding)

Yeah, I’m sure you’re right. Epipens are another weird one. I’ve worked on these types of devices - fraught with problems. But that’s another story.

This [FDA statement](https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-version-epipen) gives some clues as to what the issues are with Epipen generics.

> [@](#):
>
> Epinephrine auto-injector products are known as “combination products” because they consist of a drug (epinephrine) and a device (the auto-injector). The development of generic combination products can be more challenging than typical drug products, and the FDA regularly takes steps to help guide industry through the process. The agency works with individual companies to support their development of such complex products…

I assume what they mean by this is that it’s difficult to replicate the performance of the device (first generic was 30 years after launch of originator). There’s a whole debate here about health economics - these devices are (believe it or not) low cost affairs powered by a spring. So try making a non-infringing, low-cost, spring-powered device that matches the performance of the original.

It appears that the other pens on the US market before 2018 were not generics. This might partially explain high cost - but then look at [this](https://www.washingtonpost.com/news/to-your-health/wp/2018/08/16/fda-approves-first-generic-version-of-epipen/?utm_term=.7d4ea309a3e4):

> [@](#):
>
> Although the key ingredient is cheap and the EpiPen itself was first approved in 1987, Mylan began increasing the price of the product, from less than $100 in 2007 for a pack of two injectors to $608 today.

Hmmm. I just took a look in an old BNF on the shelf here, and in the UK these devices have a unit cost price of about $40.

I observed upthread that you need a better health system. Actually, Kobal 2 put it much better:

> [@](#):
>
> Americans have insurance Stockholm syndrome.

Ouch. Vicious but fair.

Hijack over.

j

Aside: a single generic isn’t going to make the price plummet - that only happens when you have multiple competing generics.

Second Aside: the word “generic” is used throughout by the FDA - correctly, I assume, as epinephrine, though a “biological” molecule is actually [a very simple structure](https://en.wikipedia.org/wiki/Adrenaline).

---

<div class="post-metadata">

**Author:** ![Kobal2](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/kobal2/32/20_2.png) [@Kobal2](https://boards.straightdope.com/u/Kobal2)\
**Post date:** [June 24, 2019, 9:37am UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/106 "2019-06-24T09:37:58Z")

</div>

> [@wolfpup](#):
>
> I don’t know why you say “even” Canada. If you need an ambulance in Ontario the cost is a flat fee of $45 which is waived in many circumstances (I think it’s higher in other provinces). And for any medically necessary care there is no cost at all. In fact doctors’ offices are typically not set up to deal with any kind of monetary transactions, which can actually make it tricky in some unusual case where you do actually have to pay for something, like a missed appointment.
> 
> Anyway the point is, if you suddenly need an emergency trip to the hospital, in Ontario your maximum out-of-pocket cost will be $45 no matter what care you receive or how long you stay, unless you opt for extra amenities like a fully private room or cable TV.

I said “even” because while Europe, Japan or Israel might be construed by your average American as some far away, exotic places with weird alien customs and cultures altogether Other ; and the majority of Americans will probably go their entire lives without going there.

Canada on the other hand is _right there_ ; many, many Americans regularly hop across the border ; and apart from a funny accent and a general propensity towards civility which may seem alien to your average southern neighbour y’all mostly share the same post-colonial culture ever since Nouvelle France stopped being a thing. Therefore it’s all the more puzzling that Canadians healthcare like _this_, while Americans healthcare more like this _attempt to mime a nuclear trashcan fire_.

---

<div class="post-metadata">

**Author:** ![Broomstick](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/broomstick/32/246_2.png) [@Broomstick](https://boards.straightdope.com/u/Broomstick)\
**Post date:** [June 24, 2019, 10:17am UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/107 "2019-06-24T10:17:02Z")

</div>

> [@puzzlegal](#):
>
> I tried to talk a friend into just buying some epinephrine and a syringe (which, you know, people used to use.) but he was too squeamish and insurance was paying.

Using a vial of drug and syringe requires a certain hand-eye coordination that just might not be there in an anaphylactic emergency. Having had that level of allergic reaction myself I am not at all convinced that I could physically manage that task, and with watering, swelling eyes it is entirely possible I could not see well enough to measure out the proper dose.

An epi-pen is a pre-measured dose in a delivery system that requires minimal hand-eye coordination or dexterity. It’s also designed to punch through things like clothing that might get in the way of dose delivery. It is also simple enough that an untrained bystander has a chance of delivering the proper dose properly. The housing for the device is also pretty sturdy and unlikely to break even while being hauled around by active teenagers and the like.

The last time I was in a life-threatening allergic reaction - Halloween night, 1995 - the nice EMT/paramedic used a vial and a syringe to give me the epinephrine, but he was a trained professional unlikely to panic in a life-or-death situation.

---

<div class="post-metadata">

**Author:** ![panache45](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/panache45/32/64_2.png) [@panache45](https://boards.straightdope.com/u/panache45)\
**Post date:** [June 24, 2019, 12:20pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/108 "2019-06-24T12:20:43Z")

</div>

> [@Broomstick](#):
>
> Using a vial of drug and syringe requires a certain hand-eye coordination that just might not be there in an anaphylactic emergency.

Even without an emergency, bad syringe design makes it very difficult to control the syringe with one hand. The manufacturers could correct this with a simple change… but they don’t.

---

<div class="post-metadata">

**Author:** ![puzzlegal](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/puzzlegal/32/3827_2.png) [@puzzlegal](https://boards.straightdope.com/u/puzzlegal)\
**Post date:** [June 24, 2019, 12:38pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/109 "2019-06-24T12:38:36Z")

</div>

> [@Treppenwitz](#):
>
> …  
> I observed upthread that you need a better health system. Actually, Kobal 2 put it much better:
> 
> Ouch. Vicious but fair.  
> …

No disagreement from me.

> [@Broomstick](#):
>
> Using a vial of drug and syringe requires a certain hand-eye coordination that just might not be there in an anaphylactic emergency. Having had that level of allergic reaction myself I am not at all convinced that I could physically manage that task, and with watering, swelling eyes it is entirely possible I could not see well enough to measure out the proper dose…

It was for his kid. There are other people in the household. There are other people everywhere he goes. They could have gotten fewer epi-pens and some back-up syringes.

I dunno, when I was a kid, before epipens were invented, my father had a life-threatening bee allergy. And he showed me the three places where he had stashed syringes and bottles of epinephrine, and told me how to jab him with it if he had a reaction too bad to jab himself. It might be too hard to do it if you are struggling to breath, but it’s not very hard, and I think I could have done it with that 5 minutes of training.

(As an adult I briefly had a job where I injected mice with epinephrine. It was easy, even with uncooperative subjects.)

Fortunately, it never came up. Shortly after that he had desensitizing treatments for bee venom, and they worked.

The whole epi-pen price gouging story left me with a very bitter taste in my mouth re our health system in general and the pharmaceutical industry in particular.

---

<div class="post-metadata">

**Author:** ![Grim\_Render](https://avatars.discourse-cdn.com/v4/letter/g/a87d85/32.png) [@Grim\_Render](https://boards.straightdope.com/u/Grim_Render)\
**Post date:** [June 24, 2019, 1:06pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/110 "2019-06-24T13:06:29Z")

</div>

> [@John.St](#):
>
> 1. The drug companies need a certain amount to finance development and production. The exorbitant rise in prices are caused by discounts demanded by the drug wholesalers in the US. I happen to know, that Danish Novo pays more than US$ 15 billion in discounts per year, and the wholesalers who control the sales to US hospitals and health insurance companies have become more and more greedy every year. Check Congress and diabetes.

They spend more on advertising in the US than on R&D. A signal that prices are too high by far.

Note that many other nations do as much research per person, and have far cheaper drugs. Yet the pharmas are still profitable.

---

<div class="post-metadata">

**Author:** ![Broomstick](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/broomstick/32/246_2.png) [@Broomstick](https://boards.straightdope.com/u/Broomstick)\
**Post date:** [June 24, 2019, 2:05pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/111 "2019-06-24T14:05:39Z")

</div>

> [@puzzlegal](#):
>
> It was for his kid. There are other people in the household. There are other people everywhere he goes. They could have gotten fewer epi-pens and some back-up syringes.

That is a different situation than mine - I live alone and seldom have backup.

> [@](#):
>
> I dunno, when I was a kid, before epipens were invented, my father had a life-threatening bee allergy. And he showed me the three places where he had stashed syringes and bottles of epinephrine, and told me how to jab him with it if he had a reaction too bad to jab himself. It might be too hard to do it if you are struggling to breath, but it’s not very hard, and I think I could have done it with that 5 minutes of training.

The last time I had a life-threatening allergic reaction I had projectile vomiting, explosive diarrhea, swelling pretty much everywhere that was both reducing my manual dexterity and seriously interfering with my vision, shaking, and I started to black out every time I sat up. All simultaneously. It was a bit more than just “struggling to breathe” although that was also a component - I dug some pretty impressive gouges in my own neck somewhere in there (definite feeling of strangulation going on) although at the time I was not aware of doing so. Jabbing an epi-pen into my own thigh under such circumstances would be a struggle and quite a physical feat although I’m pretty sure I could manage _that_ much.

Would be nice to have a nearby family member with syringes and medication on hand just in case I can’t save my own life but alas, I’ve outlive most of my family at this point.

I don’t have a problem with filling a syringe and injecting someone (including myself - OK, maybe a tiny twinge) for the most part - but I just don’t think I could physically do it during an episode of severe anaphylaxis. It’s not a lack of training or willingness to do it, it’s a matter of being physically incapacitated.

Epi-pens also have the advantage that _anyone_ could be coached into using one over, say, the phone. 1) grasp epo-pen pointed end _away_ from you, 2) jab pointy bit into allergic person’s thigh muscle. Can’t get much simpler than that.

Except for the whole “this costs a shit-ton of money” complication.

Don’t know if Doc Mercotan could add to what I’ve described but maybe he could give a bit more input on how impairing it can be, and how much _worse_ than what’s often depicted in the media (hell, half the time it’s treated as a joke).

Not all allergic reactions, not even all severe ones, are as bad as that but some are. It’s frightening as hell to watch it happen to someone else, it’s even worse to experience it (unless you’re unconscious and therefore not aware of anything). It’s the difference between TV/movie CPR and the real deal with bodily fluids oozing out and the sound of ribs breaking.

> [@puzzlegal](#):
>
> Fortunately, it never came up. Shortly after that he had desensitizing treatments for bee venom, and they worked.

Oh, yeah, I had five years of desensitizing treatments and they did me a world of good. Unfortunately, the treatment is not perfect and not effective for all allergies.

---

<div class="post-metadata">

**Author:** ![puzzlegal](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/puzzlegal/32/3827_2.png) [@puzzlegal](https://boards.straightdope.com/u/puzzlegal)\
**Post date:** [June 24, 2019, 3:18pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/112 "2019-06-24T15:18:45Z")

</div>

Oh, epipens are great – if you can afford them. But when the maker jacked up the price (basically because they thought they could) I hoped the encourage people who could buy fewer to do so – to reduce the profits of gouging, and to encourage them to drop the price again.

---

<div class="post-metadata">

**Author:** ![Broomstick](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/broomstick/32/246_2.png) [@Broomstick](https://boards.straightdope.com/u/Broomstick)\
**Post date:** [June 24, 2019, 4:23pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/113 "2019-06-24T16:23:38Z")

</div>

Naw, with fewer units sold they use that as a justification to jack up the price on individual units because they will claim they aren’t reaping the price-savings of volume sales.

---

<div class="post-metadata">

**Author:** ![Nava](https://avatars.discourse-cdn.com/v4/letter/n/da6949/32.png) [@Nava](https://boards.straightdope.com/u/Nava)\
**Post date:** [June 24, 2019, 4:45pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/114 "2019-06-24T16:45:33Z")

</div>

When setting up the price of a product there’s two basic ways to get as much total benefit: high volume at low price, or low volume at high price.

For luxury items, people will either not give a shit, pay the price or get a lookalike (which may even be legal, if it doesn’t look too alike). For items viewed as necessary such as medication, the instinct of people who aren’t pharma execs is “try to sell as much as possible”, because that means more people getting better; this improves both the lives of the patients and of those who care about them, and the economy of society as a whole. But for pharma execs there can be multiple benefits to going the low-volume route: among other things, it means you don’t need to have the facilities and the people to make and distribute as much as you can sell, something which depending on the process can mean shipping stuff to and fro between a lot of different factories\*. So, price your stuff to sell as much as you’ve decided you wanna make: not more, because if you sell too much you need more machinery and more trained people.

- One of my pharma clients had a process for a very common analgesic which used 20 steps in 20 different factories (including one that appeared in the list twice at different points) and every continent except for Anctartica. And I think they didn’t have a factory there because they couldn’t.

---

<div class="post-metadata">

**Author:** ![Wolf333](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/wolf333/32/3460_2.png) [@Wolf333](https://boards.straightdope.com/u/Wolf333)\
**Post date:** [June 24, 2019, 4:58pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/115 "2019-06-24T16:58:54Z")

</div>

> [@puzzlegal](#):
>
> Thank you.
> 
> I’m sure there are other issues for other drugs. For instance, as best as i can tell, the problem with the EpiPen boiled down to not many drug companies, and none that really wanted to make a cheaper version. I tried to talk a friend into just buying some epinephrine and a syringe (which, you know, people used to use.) but he was too squeamish and insurance was paying.

When I go into shock I lose my vision and fine motor skills\*. Trying to give myself a shot is out of the question.

The last two times I had to use my pen, I did it blind.

---

<div class="post-metadata">

**Author:** ![Nava](https://avatars.discourse-cdn.com/v4/letter/n/da6949/32.png) [@Nava](https://boards.straightdope.com/u/Nava)\
**Post date:** [June 24, 2019, 5:09pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/116 "2019-06-24T17:09:17Z")

</div>

> [@Kobal2](#):
>
> Maybe that’s just a term of art ?

I still say that, while I do certainly admit to the “Hispanic” bit, if you’re a whore and you’re fucking you’re getting paid for the job you do, so what’s the stupid bit supposed to be?

---

<div class="post-metadata">

**Author:** ![puzzlegal](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/puzzlegal/32/3827_2.png) [@puzzlegal](https://boards.straightdope.com/u/puzzlegal)\
**Post date:** [June 24, 2019, 5:53pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/117 "2019-06-24T17:53:49Z")

</div>

> [@Wolf333](#):
>
> When I go into shock I lose my vision and fine motor skills\*. Trying to give myself a shot is out of the question.
> 
> The last two times I had to use my pen, I did it blind.

As I mentioned above, in this case, it was a kid and there would be a parent around to administer the drug. I understand that injecting yourself with a syringe is not something you want to do when you are having a reaction.

---

<div class="post-metadata">

**Author:** ![Northern\_Piper](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/northern_piper/32/5304_2.png) [@Northern\_Piper](https://boards.straightdope.com/u/Northern_Piper)\
**Post date:** [June 24, 2019, 6:08pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/118 "2019-06-24T18:08:41Z")

</div>

> [@Kobal2](#):
>
> … y’all mostly share the same post-colonial culture ever since Nouvelle France stopped being a thing. Therefore it’s all the more puzzling that Canadians healthcare like _this_, while Americans healthcare more like this _attempt to mime a nuclear trashcan fire_.

This is actually one of the big picture issues that Canadian poli-sci types wonder about: why are Canadians more generally accepting of a stronger government presence than our southern cousins?

Without hijacking this thread, the general thought is that the US Revolt created not just one North American nation, but two, the US and Canada. As well, the inhabitants of the two countries self-sorted for ideologies: the southerners for suspicion of government, the northerners for reliance on government, particularly for domestic security. Those initial differences then got magnified by the settlement patterns, and also by immigration and political ties to the UK for the northerners.

---

<div class="post-metadata">

**Author:** ![Treppenwitz](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/treppenwitz/32/3445_2.png) [@Treppenwitz](https://boards.straightdope.com/u/Treppenwitz)\
**Post date:** [June 24, 2019, 6:20pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/119 "2019-06-24T18:20:59Z")

</div>

> [@Nava](#):
>
> One of my pharma clients had a process for a very common analgesic which used 20 steps in 20 different factories (including one that appeared in the list twice at different points) and every continent except for Anctartica. And I think they didn’t have a factory there because they couldn’t.

OK, Nava, you got my attention. _Twenty?_ This has to be the synthesis, right? And presumably done principally to apportion added value to favourable tax regimes? And I still can’t think of a common analgesic which could match the description.

j

---

<div class="post-metadata">

**Author:** ![Bookkeeper](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/bookkeeper/32/281_2.png) [@Bookkeeper](https://boards.straightdope.com/u/Bookkeeper)\
**Post date:** [June 24, 2019, 7:41pm UTC](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676/120 "2019-06-24T19:41:14Z")

</div>

> [@wolfpup](#):
>
> I don’t know why you say “even” Canada. If you need an ambulance in Ontario the cost is a flat fee of $45 which is waived in many circumstances (I think it’s higher in other provinces). And for any medically necessary care there is no cost at all. In fact doctors’ offices are typically not set up to deal with any kind of monetary transactions, which can actually make it tricky in some unusual case where you do actually have to pay for something, like a missed appointment.
> 
> Anyway the point is, if you suddenly need an emergency trip to the hospital, in Ontario your maximum out-of-pocket cost will be $45 no matter what care you receive or how long you stay, unless you opt for extra amenities like a fully private room or cable TV.

And note that the $45 is not for revenue generation, it’s simply to discourage people from using the ambulance instead of a taxi for non-emergency trips to the hospital.

[Previous page](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676.md?page=5)

[Next page](https://boards.straightdope.com/t/the-high-price-of-insulin-is-killing-us-citizens/835676.md?page=7)
